Costing and Cost Analysis in Randomized Controlled Trials Daniel PolskyHenry Glick Leading Article 17 September 2012 Pages: 179 - 188
Cost of Illness of Glaucoma Richard G. FiscellaJeff LeeJohn Walt Review Article 17 September 2012 Pages: 189 - 198
The Costs of Treating Breast Cancer in the US Jonathan D. CampbellScott D. Ramsey Review Article 17 September 2012 Pages: 199 - 209
Preferences of GPs and Patients for Preventive Osteoporosis Drug Treatment Esther W. de Bekker-GrobMarie-Louise Essink-BotEwout W. Steyerberg Original Research Article 17 September 2012 Pages: 211 - 219
The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy Alone Peter LindgrenMartin BuxtonBengt Jönsson Original Research Article 17 September 2012 Pages: 221 - 230
Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium Lieven AnnemansVanessa RémyNathalie Largeron Original Research Article 17 September 2012 Pages: 231 - 245
Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan Ataru IgarashiHiroki TakumaKiichiro Tsutani Original Research Article 17 September 2012 Pages: 247 - 261
Methods of Economic Evaluation for the German Statutory Healthcare System J. Jaime Caro Correspondence 17 September 2012 Pages: 263 - 264
Methods of Economic Evaluation for the German Statutory Healthcare System Thomas MittendorfWolfgang GreinerJohann-Matthias von der Schulenburg Correspondence 17 September 2012 Pages: 265 - 265
